Does plasma copeptin level at admission predict final infarct size in ST-elevation myocardial infarction
- 15 June 2016
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 219, 326-330
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Plasma copeptin levels are associated with prognosis of severe acute pancreatitisPeptides, 2014
- Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarctionClinical Research in Cardiology, 2011
- Copeptin: A novel, independent prognostic marker in patients with ischemic strokeAnnals of Neurology, 2009
- Copeptin: clinical use of a new biomarkerTrends in Endocrinology & Metabolism, 2008
- COPEPTIN, A STABLE PEPTIDE OF THE ARGININE VASOPRESSIN PRECURSOR, IS ELEVATED IN HEMORRHAGIC AND SEPTIC SHOCKShock, 2007
- C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial InfarctionCirculation, 2007
- Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infectionsEuropean Journal of Clinical Investigation, 2007
- Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of VasopressinClinical Chemistry, 2006
- Properties of Human Vasopressin Precursor Constructs: Inefficient Monomer Folding in the Absence of Copeptin as a Potential Contributor to Diabetes InsipidusBiochemistry, 2004
- Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human PlasmaJournal of Clinical Investigation, 1973